Life sciences
Experts in healthcare access
The access challenges facing healthcare products are becoming more and more complex. With direct experience serving stakeholders across the U.S. healthcare system, we can help you understand the market, identify actionable insights, develop market-ready strategies, and execute to the top of your potential.
Our solutions are tailored to your needs, whether you’re focused on small molecule pharma, gene and cell therapies, rare disease, biosimilars, or medical devices.
Hear from
Milliman Life Sciences leaders
Watch our experts in conversation on key topics affecting the industry.
Read our latest thought leadership
Increasing diversity in clinical trials
Milliman health researchers discuss strategies and benefits of making sure new medical treatments are tested in patients from a range of backgrounds.
Trends in psychotropic and other select central nervous system drug overdose deaths
Appropriate clinical supervision and prescription management may help mitigate the overdose risks associated with psychotropics or select CNS medications.
Evaluating supervised machine learning classification models in healthcare analytics
Artificial intelligence tools, such as machine learning, have the potential to improve healthcare operations, diagnosis detection and workflows.
Learn more about our comprehensive suite of services
Milliman Consolidated Health Cost Guidelines™ databases
Claim line detail for medical and prescription drug claims and enrollment.
| Heading | Content | Lines of business | Estimated lives represented | |
|---|---|---|---|---|
| Milliman Proprietary Data | CHSD+ | The Consolidated Health Cost Guidelines Databases (CHSD) includes claim line detail for medical and prescription drug claims and enrollment | Commercial Medicare Advantage Managed Medicaid |
Almost 90 million |
| Milliman Proprietary Data | Medicare PDCD | The Medicare Prescription Drug Consolidated Database includes drug claims and enrollment | Medicare Part D | Over 6 million |
| Industry Data | CMS 100% Research Identifiable Files | Claim line detail for medical and prescription drug claims and enrollment | Fee-for-service (FFS) Medicare Medicare Advantage Medicaid |
All beneficiaries |
| Industry Data | CMS 5% Sample / 100% Data Sets | Claim line detail for medical claims and enrollment | Fee-for-Service (FFS) Medicare | All beneficiaries |
| Industry Data | MarketScan | Claim line detail for medical and prescription drug claims and enrollment | Commercial | 35 million |
| Milliman Proprietary Data | State Discharge | Inpatient discharges, no membership | All | 100% of Admissions in Available States |
Contact us
We’re here to help you break through complex challenges and achieve next-level success.